SEC Form 4 · accession 0001571049-17-005398
PHIBRO ANIMAL HEALTH CORP · PAHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jack Bendheim
Officer — President and CEO · Director · 10% Owner
Period of report
May 23, 2017
Accepted (ET)
May 25, 2017 · 9:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1,F2 | May 23, 2017 | C | 72,975 | — | A | 96,000 | I | See |
| Class A Common StockF3,F4,F2 | May 23, 2017 | S | 16,000 | $34.46 | D | 80,000 | I | See |
| Class A Common StockF3,F5,F2 | May 24, 2017 | S | 16,000 | $34.75 | D | 64,000 | I | See |
| Class A Common StockF3,F6,F2 | May 25, 2017 | S | 16,000 | $34.80 | D | 48,000 | I | See |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Class B Common StockF1,F2 | — | May 23, 2017 | C | 72,975 | D | — | — | Class A Common Stock | 72,975 | 20,814,836 | I |
Explanation of responses
- F1The Class B Common Stock was convertible into Class A Common Stock at any time on a one-for-one basis, and had no expiration date.
- F2The securities are held by BFI Co., LLC. Mr. Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI Co., LLC and may be deemed to have shared voting and investment power over the securities held by BFI Co., LLC. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- F3The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC on March 14, 2016.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.25 to $34.65, inclusive.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.35 to $35.03, inclusive.
- F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.50 to $35.15, inclusive